company? Let’s change
that.
Don't see your company?
Create a company profileAnadys Pharmaceuticals, a biopharmaceutical company, develops medicines for the treatment of hepatitis C.
Applied Proteomics offers a protein biomarker discovery platform to advance the application of proteomics.
Arena Pharmaceuticals is focused on delivering solutions for cardiovascular, central nervous system, inflammatory and metabolic diseases.
Arytha Biosciences is a nanotechnology-driven and research-focused biotech company.
BioRegenerative Sciences is a provider of therapeutic products that rejuvenate the body to produce natural health and beauty.
BioTuring deliver important algorithms and software to tackle biomedical challenges.
Bloom Science is a platform Biotechnology company discovering and developing revolutionary new drugs.
Cell IDx is the technology leader in multiplexed cellular immunodiagnostics.
Comprendia is the only life science marketing firm.
Denovium is an artificial intelligence company pioneering novel AI methods to accelerate innovation in biopharma.
Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health In September 2020, Evofem launched Phexxi, the first and only hormone-free, on-demand, prescription birth control available in the U.S. that women use only when they have sex. The Company is also advancing Phexxi through a Phase 3 registrational trial for two potential new indications - the prevention of chlamydia and gonorrhea in women, with top-line data expected in October 2022.
Exalys Therapeutics is focused on the development of first-in-class therapies for the treatment of inflammatory disorders.
Forge Therapeutics is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry.
Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.
Mapp Biopharmaceutical was created to develop novel pharmaceuticals for the prevention and treatment of infectious diseases.
Maravai LifeSciences enables the miracles of science and improves the human condition through its portfolio of market-leading companies and proprietary technologies. Biomedical innovation is dependent on a reliable supply of reagents in the fields of nucleic acid production and biologics safety testing. From inventive startups to many of the world's leading biopharma, vaccine, diagnostics and cell and gene therapy companies, customers turn to Maravai to solve their complex discovery challenges and help them streamline and scale from research through clinical trials. TriLink BioTechnologies is a global leader in RNA synthesis and scale up, including mRNA production, yield-enhancing proprietary CleanCap® mRNA capping technology, and CDMO services ranging from research to GMP grades. Glen Research leads in specialty reagents for DNA and RNA oligonucleotide synthesis for a broad range of applications. Cygnus Technologies developed the market for bioprocess impurity detection, process-related impurity analytics and viral clearance prior to human trials, regulatory approval and commercial release. Maravai holds a number of patents and offers innovative products and services including CleanCap®, CleanAmp®, GMPLink™, Antibody Affinity Extraction™ (AAE™), EndonucleaseGTP®, PROTEIN A MIX-N-GO™, MockV™, Sterling™, Glen Pak™, Glen Gel-Pak™, Poly-Pak™. Maravai's portfolio companies are ISO-9001:2015 certified and have earned hundreds of thousands of citations in peer-reviewed scientific publications. Founded in 2014 and headquartered in San Diego, Maravai LifeSciences is online at www.maravai.com.
Nereus Pharmaceuticals engages in the discovery and development of therapeutics for the treatment of infectious diseases and inflammation.
Nucleus Biologics is a San Diego based biotechnology company and a global provider of media and supplements for the cell and gene therapy space. Their mission is to speed the time from scientific discovery to cure by driving reproducibility through Precision Cell Culture products and tools. Nucleus Biologics delivers innovative, transparent and cGMP products and services with the goal of disrupting the market and eliminating antiquated practices and products. Ultimately, Nucleus Biologics strives to create a new paradigm that serves both scientists and clinicians, while reducing the environmental footprint of cell culture.
Developing innovative three-dimensional medical imaging technologies for point of care
Uqora is a biotechnology company focused on urinary tract health. Uqora has developed innovative solutions for proactive urinary health.